A Ban, Not a Moratorium, on Human Embryo Modification
By Tina Stevens and Stuart Newman,
The Berkeley Daily Planet
| 06. 28. 2019
The question of whether embryos can be safely engineered has long been settled: they cannot.
A twin birth in China last October raised ominous questions. The baby girls had been genetically edited as embryos, with the untested methods providing no confidence in healthy outcomes. The subsequent fallout has been confusing: a blue-ribbon group of scientists and ethicists sent a letter to the Secretary of Health and Human Services in late April recommending a moratorium, following a similar call in the scientific journal Nature. In both cases, the door was left open to clinical use if and when relevant stakeholders are satisfied it should proceed. And if the federal government won’t fund it, the tax-payer supported California Institute of Regenerative Medicine (CIRM) could.
When the relevant science (developmental biology) is considered, however, it becomes evident that embryo modification cannot proceed safely. Time-buying measures such as moratoria are simply strategies to deny this reality and enable its eventual implementation. But the question of whether embryos can be safely engineered has long been settled: they cannot. This is clear from experiments on animal embryos, where altered genes are seen to behave in unpredicted ways, and in human...
Related Articles
By Diaa Hadid and Shweta Desai, NPR | 01.29.2026
MUMBRA, India — The afternoon sun shines on the woman in a commuter-town café, highlighting her almond-shaped eyes and pale skin, a look often sought after by couples who need an egg to have a baby.
"I have good eggs,"...
By George Janes, BioNews | 01.12.2026
A heart attack patient has become the first person to be treated in a clinical trial of an experimental gene therapy, which aims to strengthen blood vessels after coronary bypass surgery.
Coronary artery bypass surgery is performed to treat...
By Staff, ScienceDaily | 01.05.2026
Scientists at UNSW Sydney have developed a new form of CRISPR technology that could make gene therapy safer while also resolving a decades-long debate about how genes are switched off. The research shows that small chemical markers attached to DNA
...
Following a long-standing CGS tradition, we present a selection of our favorite Biopolitical Times posts of the past year.
In 2025, we published up to four posts every month, written by 12 authors (staff, consultants and allies), some in collaboration and one simply credited to CGS.
These titles are presented in chronological order, except for three In Memoriam notices, which follow. Many more posts that are worth your time can be found in the archive. Scroll down and “VIEW...